Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) CEO John Farquhar sold 35,010 shares of the firm’s stock in a transaction dated Thursday, September 10th. The stock was sold at an average price of $46.42, for a total value of $1,625,164.20. Following the transaction, the chief executive officer owned 325,804 shares of the company’s stock, valued at $15,123,821.68. This trade represents a 9.70% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
John C.M. Farquhar also recently made the following trade(s):
- On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total value of $194,500.00.
- On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00.
- On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
- On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The stock was sold at an average price of $39.06, for a total transaction of $607,773.60.
- On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total transaction of $638,730.22.
- On Friday, July 10th, John Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
- On Wednesday, June 24th, John Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00.
Heartflow Stock Down 0.7%
HTFL traded down $0.34 during trading on Monday, reaching $49.54. 1,619,526 shares of the stock traded hands, compared to its average volume of 1,556,569. The stock’s 50-day moving average is $35.52 and its 200 day moving average is $30.84. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $51.78. The stock has a market capitalization of $4.31 billion and a PE ratio of -27.07.
Analyst Ratings Changes
HTFL has been the topic of several recent analyst reports. Stifel Nicolaus boosted their price target on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th. JPMorgan Chase & Co. lifted their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Robert W. Baird set a $45.00 target price on shares of Heartflow in a research report on Friday, August 14th. Wells Fargo & Company raised their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Finally, Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $44.88.
View Our Latest Research Report on HTFL
Institutional Investors Weigh In On Heartflow
Several hedge funds and other institutional investors have recently modified their holdings of HTFL. XXEC Inc. bought a new position in shares of Heartflow in the 2nd quarter worth $2,524,764,000. Quantinno Capital Management LP bought a new stake in Heartflow during the 1st quarter valued at $1,734,000. Sei Investments Co. raised its holdings in Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock worth $1,631,000 after buying an additional 51,895 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of Heartflow in the second quarter valued at $19,096,000. Finally, Handelsbanken Fonder AB bought a new stake in Heartflow during the 2nd quarter worth approximately $910,000.
Heartflow Company Profile
Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.
The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFRCT).
Further Reading
- Five stocks we like better than Heartflow
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
